Evidence map›Paper›PMID 37739445›Full record

ArticleBMJ case reports2023

Angioedema without urticaria after recent initiation of celecoxib.

Vivek Vardhan Jasti, Jay Anderson, Ifa Abdujelil

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Vivek Vardhan JastiInternal Medicine, OhioHealth Riverside Methodist Hospital, Columbus, Ohio, USA.
Jay AndersonInternal Medicine, OhioHealth Riverside Methodist Hospital, Columbus, Ohio, USA jay.anderson@ohiohealth.com.
Ifa AbdujelilMedical Education, Ohio University College of Osteopathic Medicine, Athens, Ohio, USA.
OhioHealth · USOhio University · USRiverside Methodist Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angioedema is potentially life-threating swelling of integument and mucosa that has multiple potential aetiologies with varying mechanisms. Drug-induced angioedema is often easily correlated with the offending agent and can be prevented with discontinuation of the medication. Many medications have now been implicated in drug-induced angioedema but the two most common are ACE inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs). This case highlights severe angioedema secondary to celecoxib and reviews varying aetiologies of angioedema and NSAID hypersensitivity reactions.

Indexed as

AngioedemaUrticariaAnti-Inflammatory Agents, Non-SteroidalCelecoxibHumansSkinAnti-Inflammatory Agents, Non-SteroidalCelecoxibAdult intensive careMedical managementUnwanted effects / adverse reactions

Identifiers

PMID37739445
PMCPMC10533717
OpenAlexW4386969676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.